Skip to Content

What type of drug is Ajovy?

Answers (1)

Official Answer by 15 Oct 2018

Ajovy (fremanezumab-vfrm) from Teva Pharmaceuticals is an injectable migraine preventive for adults that targets the calcitonin gene-related peptide (CGRP) and prevents CGRP from binding to its receptor site. When CGRP binds to the receptor, a cascade of events such as vasodilation and protein leakage begin that leads to the inflammation and pain associated with migraine. Ajovy is a monoclonal antibody and selectively targets the CGRP ligand (a molecule that produces a signal by binding to a site on a target protein).

Two other CGRP antagonists have also been approved:

  • Emgality (galcanezumab-gnlm) from Eli Lilly has a similar mechanism as Ajovy; it binds to the CGRP ligand and blocks its binding to the receptor to help prevent migraine pain.
  • Aimovig (erenumab-aooe) from Amgen was the first approved CGRP antagonist and works in a slightly different way than Ajovy or Emgality. Aimovig actually binds potently and selectively to the CGRP receptor (not the ligand) to block CGRP activation, thereby preventing the migraine pain. free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What disease is Elzonris (tagraxofusp-erzs) used to treat?

Updated 7 Jan 2019 1 answerFAQ by

How do you use the ProAir Digihaler?

Updated 7 Jan 2019 1 answerFAQ by

How many biosimilars have been approved in the United States?

Updated 8 Jan 2019 1 answerFAQ by

What are the brands of sumatriptan?

Updated 5 Feb 2019 1 answerFAQ by

What is botulinum toxin used to treat?

Updated 14 Feb 2019 1 answerFAQ by